QV Investors’s NRC Health Common Stock NRC Stock Holding History

QV Investors’s Portfolio NRC Stock Details NRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.04M	Sell	372,503 -8,807	-2%	-$163K	0.62%	44
2026 Q1	$6.47M	Hold	381,310	–	–	0.52%	47
2025 Q4	$7.16M	Hold	381,310	–	–	0.59%	44
2025 Q3	$4.87M	Hold	381,310	–	–	0.42%	45
2025 Q2	$6.41M	Buy	381,310 +26,950	+8%	+$364K	0.63%	39
2025 Q1	$4.54M	Hold	354,360	–	–	0.46%	44
2024 Q4	$6.25M	Buy	354,360 +15,370	+5%	+$292K	0.64%	41
2024 Q3	$7.75M	Buy	338,990 +610	+0.2%	+$13.8K	0.68%	40
2024 Q2	$7.77M	Sell	338,380 -3,870	-1%	-$119K	0.73%	41
2024 Q1	$13.6M	Sell	342,250 -52,852	-13%	-$2.09M	1.18%	33
2023 Q4	$15.6M	Sell	395,102 -56,048	-12%	-$2.35M	1.41%	25
2023 Q3	$20M	Hold	451,150	–	–	2.08%	17
2023 Q2	$19.6M	Buy	451,150 +700	+0.2%	+$30.8K	1.77%	21
2023 Q1	$19.6M	Buy	450,450 +580	+0.1%	+$25.6K	1.83%	22
2022 Q4	$16.8M	Sell	449,870 -14,450	-3%	-$559K	1.61%	22
2022 Q3	$18.5M	Buy	464,320 +1,040	+0.2%	+$38.5K	1.78%	22
2022 Q2	$17.7M	Hold	463,280	–	–	1.61%	26
2022 Q1	$18.4M	Buy	+463,280	New	+$18.1M	1.31%	27

Other funds holding NRC

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

WIC

Willis Investment Counsel Gainesville, Georgia $2.1B AUM 24.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

FMII

Farmers & Merchants Investments Inc Lincoln, Nebraska $4.13B AUM 32.58% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

QV Investors's NRC Position: Q2 2026 in Review

QV Investors reduced its NRC Health Common Stock (NRC) stake by 2.3% in Q2 2026, selling an estimated $163K and leaving 372,503 shares worth $8.04M. The position accounts for 0.62% of the portfolio, ranked #44.

QV Investors first reported a position in NRC in Q1 2022 and has held it in 18 quarters since. The position peaked at $20M in Q3 2023. 124 funds tracked by Wall St. Rank hold NRC as of Q2 2026.

QV Investors held 372,503 shares of NRC Health Common Stock worth $8.04M as of Q2 2026.
QV Investors sold 8,807 NRC Health Common Stock shares in Q2 2026, an estimated $163K.
NRC Health Common Stock made up 0.62% of QV Investors's portfolio in Q2 2026, its #44 holding.
QV Investors first reported a position in NRC Health Common Stock in Q1 2022 and has held it in 18 quarters since.
QV Investors's NRC Health Common Stock position peaked at $20M in Q3 2023.
124 funds tracked by Wall St. Rank held NRC Health Common Stock as of Q2 2026.

Based on QV Investors's 13F filing for Q2 2026, filed 21 Jul 2026.